Procurement is to receive glass pathology slides of cancer.
Ended Purchase Order Awarded Last action
- Contract number
- 75F40124P00278
- Awardee
-
Rubix Strategies LLC UEI XDWWTKLJ8KS3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $44,250
Award facts
- Contract value 64% obligated
-
- $44,250.00 Current, with exercised options
- $69,250.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $44,250 |
About this award
This federal contract, valued at $69,250.00, was awarded by the Food and Drug Administration (FDA) to Rubix Strategies LLC, a minority-owned, small disadvantaged business certified as a Historically Underutilized Business Zone (HUBZone) firm. The contract is for the procurement of glass pathology slides of cancer, which aligns with the FDA's mission to protect public health. As a total small business set-aside contract, this award provides an opportunity for a specialized small business to support the FDA's work in the field of cancer research and diagnostics. Rubix Strategies LLC, doing business as Rubix LS, is a limited liability company that has demonstrated expertise in providing scientific, healthcare, and research-related services to various federal agencies, including the Department of Veterans Affairs and the Defense Health Agency.
Quick answers
Who was awarded contract 75F40124P00278?
75F40124P00278 was awarded to Rubix Strategies LLC by Food and Drug Administration (Department of Health and Human Services) on July 22, 2024.
How much is contract 75F40124P00278 worth?
The government has obligated $44,250 on 75F40124P00278. Its potential value, with all options, is $69,250.
Was contract 75F40124P00278 competed?
The extent of competition for 75F40124P00278 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award